文献速递肝肾功能剂量调整特殊人群用药

妊娠期6β-羟基皮质醇未结合固有形成清除率是CYP3A4活性生物标志物

Unbound Intrinsic Formation Clearance of 6β-Hydroxycortisol Is a Useful Biomarker of CYP3A4 Activity during Pregnancy.
PubMed 文献 · Clin Pharmacol Ther · 2026-10-12

研究纳入47名女性,比较晚孕期与产后血浆和尿液中皮质醇、可的松及6β-羟基皮质醇,计算6β-羟基皮质醇未结合固有形成清除率。晚孕期该清除率增加1.8倍,对应肝CYP3A活性增加2.1倍,且在CYP3A5表达者与非表达者中均观察到升高;皮质醇未结合分数显著下降。提示该指标可作为妊娠期CYP3A活性生物标志物。

要点

  • 晚孕期6β-羟基皮质醇未结合固有形成清除率升高1.8倍,对应肝CYP3A活性升高2.1倍。
  • 该升高在CYP3A5表达者与非表达者中均出现。
  • 晚孕期皮质醇未结合分数显著下降,模型归因于CBG表达及结合亲和力增加。

核心结论

  • 6β-羟基皮质醇未结合固有形成清除率是妊娠期肝CYP3A活性的稳健生物标志物。

研究设计与样本

  • 研究纳入47名女性,在晚孕期和产后采集血浆与尿液,测定皮质醇、可的松和6β-羟基皮质醇并计算相关清除率参数。

主要发现

  • 晚孕期6β-羟基皮质醇形成清除率增加1.3倍,而皮质醇未结合分数显著下降。
  • 6β-羟基皮质醇未结合固有形成清除率增加1.8倍,对应肝CYP3A活性增加2.1倍。
  • 该清除率升高在CYP3A5表达者和CYP3A5非表达者中均被观察到。
  • 晚孕期皮质醇和6β-羟基皮质醇的肾清除率增加超过计算出的滤过清除率增加,提示转运体介导的分泌增强。
  • 皮质醇未结合分数下降可由CBG表达增加及皮质醇与CBG结合亲和力增加的模型解释。

临床怎么用

  • 该生物标志物可用于未来研究刻画妊娠期及产后CYP3A活性变化的时间进程。
  • 皮质醇和6β-羟基皮质醇的肾清除率可能作为肾脏OCT和MATE活性的生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pregnancy results in multiple physiological changes that impact drug disposition. For example, hepatic CYP3A activity and renal transporter-mediated clearance increase in late pregnancy, but the time course of these changes across pregnancy is not known. Endogenous biomarkers offer a minimally invasive approach to characterize pharmacokinetic changes during pregnancy and postpartum. The goal of this study was to determine whether 6β-OH-cortisol formation clearance (CLf,OHCOL) can be used as a biomarker of hepatic CYP3A activity during pregnancy. Thus, we measured cortisol, cortisone, and 6β-OH-cortisol in plasma and urine from 47 women during late pregnancy and postpartum and calculated the CLf,OHCOL, unbound fraction (fu), unbound intrinsic CLf (CLf,u,int,OHCOL), and renal clearance (CLr). CLf,OHCOL increased 1.3-fold in late pregnancy while cortisol fu decreased significantly. CLf,u,int,OHCOL increased 1.8-fold, corresponding to a 2.1-fold increase in hepatic CYP3A activity. The increase in CLf,u,int,OHCOL was observed in CYP3A5 expressors and in CYP3A5 nonexpressors. In late pregnancy, the increase in CLr,cortisol and CLr,OHCOL exceeded the calculated increase in filtration clearance, suggesting increased transporter-mediated secretion. The decreased fu of cortisol during pregnancy was captured by a model incorporating increased expression of corticosteroid binding globulin (CBG) and increased binding affinity of cortisol to CBG. These data suggest that CLf,u,int,OHCOL is a robust biomarker of CYP3A activity during pregnancy and could be used in future studies to characterize the time course of changes in CYP3A activity across gestation and postpartum. Further, CLr,cortisol and CLr,OHCOL may be biomarkers of kidney OCT and MATE activity and could be used to evaluate kidney transporter activity during pregnancy.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Authement AK, Hebert MF, Fay EE, et al. Unbound Intrinsic Formation Clearance of 6β-Hydroxycortisol Is a Useful Biomarker of CYP3A4 Activity during Pregnancy. Clin Pharmacol Ther. 2026. PMID: 42864697. doi:10.1002/cpt.70519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。